MedTrace Logo

Role of Oral Tramadol 50 mg in Reducing Pain During Colposcopy-directed Cervical Biopsy

NCT03532841 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 250

Last updated 2018-05-22

No results posted yet for this study

Summary

The study objective is to evaluate the effectiveness of oral tramadol 50 mg in reducing pain during the colposcopy-directed cervical biopsy.half of the patients will receive oral tramadol tablets and the other half will receive a placebo.

Conditions

  • Cervical Biopsy

Interventions

DRUG

an oral tramadol 50 mg(Tramal, Memphis, Giza, Egypt) tablet

Group I will receive an oral tramadol 50 mg(Tramal, Memphis, Giza, Egypt) tablet one hour before the procedure.

DRUG

Placebo Oral Tablet

placebo tablet of the same shape,color and taste will be given in the placebo arm

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Principal Investigators

  • AHMED SAMY, MD · Cairo University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-05-15
Primary Completion
2018-08-20
Completion
2018-08-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03532841 on ClinicalTrials.gov